Table 2.
Distribution of participant characteristics by race/ethnicity*: The Multi-Ethnic Study of Atherosclerosis 2011–2013
| Participant characteristics | Overall | White | Black | Hispanic | Chinese-American |
|---|---|---|---|---|---|
| n = 2041 | 739 | 572 | 487 | 243 | |
| Demographics | |||||
| Age, years | 68.4 ± 9.1 | 68.4 ± 9.1 | 68.8 ± 9.0 | 68.4 ± 9.4 | 67.7 ± 9.0 |
| ≤67 | 1026 (50.3) | 378 (51.1) | 279 (48.8) | 245 (50.3) | 124 (51.0) |
| >67 | 1015 (49.7) | 361 (48.9) | 293 (51.2) | 242 (49.7) | 119 (49.0) |
| Sex, n (%) | |||||
| Males | 947 (46.4) | 343 (46.4) | 256 (44.8) | 229 (47.0) | 119 (49.0) |
| Female | 1094 (53.6) | 396 (53.6) | 316 (55.2) | 258 (53.0) | 124 (51.0) |
| Education, n (%) | |||||
| High school or less | 638 (31.3) | 129 (17.5) | 137 (24.0) | 296 (60.8) | 76 (31.3) |
| College/associates | 597 (29.3) | 179 (24.3) | 226 (39.7) | 135 (27.7) | 57 (23.5) |
| Bachelors/graduate | 802 (39.4) | 429 (58.2) | 207 (36.3) | 56 (11.5) | 110 (45.3) |
| Annual income, n (%) | |||||
| <$25000 | 538 (27.1) | 85 (11.8) | 132 (24.0) | 222 (46.9) | 99 (41.3) |
| $25000–$39999 | 361 (18.2) | 99 (13.8) | 131 (23.8) | 101 (21.4) | 30 (12.5) |
| $40000–$74000 | 522 (26.3) | 222 (30.8) | 148 (26.9) | 102 (21.6) | 50 (20.8) |
| >$74000 | 563 (28.4) | 314 (43.6) | 140 (25.4) | 48 (10.2) | 61 (25.4) |
| Behavioral and physiologic characteristics | |||||
| BMI, kg/m2 | |||||
| <25 | 555 (27.2) | 229 (31.1) | 95 (16.6) | 76 (15.6) | 155 (63.8) |
| 25–29.9 | 769 (37.7) | 291 (39.5) | 200 (35.0) | 201 (41.3) | 77 (31.7) |
| ≥30 | 714 (35.0) | 217 (29.4) | 276 (48.3) | 210 (43.1) | 11 (4.5) |
| Physical activity (MET-Min/Wk) | 2739 ± 5.5 | 3161 ± 4.1 | 2834 ± 6.2 | 2088 ± 8.1 | 2807 ± 3.4 |
| Smoking status, n (%) | |||||
| Never | 955 (47.1) | 306 (41.5) | 235 (41.6) | 230 (47.5) | 184 (76.0) |
| Former | 928 (45.8) | 386 (52.4) | 265 (46.9) | 226 (46.7) | 51 (21.0) |
| Current | 145 (7.2) | 45 (6.1) | 65 (11.5) | 28 (5.8) | 7 (2.9) |
| Use alcohol, n (%) | 878 (43.3) | 453 (61.5) | 237 (41.9) | 150 (31.0) | 38 (15.7) |
| CES-D score | 8.1 ± 7.6 | 7.8 ± 7.3 | 7.9 ± 7.5 | 9.5 ± 8.3 | 6.7 ± 6.5 |
| CES-D | |||||
| <16 | 1715 (85.5) | 633 (87.0) | 486 (86.8) | 381 (79.9) | 215 (89.6) |
| ≥16 | 290 (14.5) | 95 (13.0) | 74 (13.2) | 96 (20.1) | 25 (10.4) |
| Medication use, n (%)† | |||||
| No | 1752 (86.0) | 567 (76.8) | 521 (91.2) | 432 (88.9) | 232 (95.9) |
| Yes | 285 (14.0) | 171 (23.2) | 50 (8.8) | 54 (11.1) | 10 (4.1) |
Binary outcomes as number and frequency. Continuous variables are expressed as means ± SD.
*There were statistically significant differences by race at p < 0.05 for all participant characteristics except age (p = 0.59), gender (p = 0.90), and smoking status (p = 0.88).
†Use of benzodiazepines, tricyclic antidepressants, non-tricyclic antidepressants other than MAOI, or norepinephrine-dopamine reuptake inhibitors.